Share This Page
Drug Price Trends for NDC 23155-0019
✉ Email this page to a colleague
Average Pharmacy Cost for 23155-0019
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SULFASALAZINE 500 MG TABLET | 23155-0019-01 | 0.18468 | EACH | 2025-11-19 |
| SULFASALAZINE 500 MG TABLET | 23155-0019-01 | 0.18208 | EACH | 2025-10-22 |
| SULFASALAZINE 500 MG TABLET | 23155-0019-01 | 0.18042 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 23155-0019
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 23155-0019
Introduction
The pharmaceutical industry continually evolves through technological innovation, regulatory shifts, and market dynamics. A comprehensive understanding of a specific drug’s market landscape and price trajectory is vital for stakeholders, including manufacturers, investors, and healthcare providers. This analysis focuses on NDC 23155-0019, providing insights into its current market status, competitive positioning, regulatory context, and projected pricing trends.
Drug Overview
NDC 23155-0019 corresponds to a specific pharmaceutical product registered with the FDA’s National Drug Code Directory. While detailed pharmacologic specifics are proprietary, this NDC typically signifies a marketed biologic or small-molecule medication. Clarification of the drug’s indication, formulation, and approval status is essential; however, assuming it is an FDA-approved therapeutic, it occupies a defined niche within its therapeutic class.
Market Landscape and Competitive Environment
Market Size and Demand Drivers
The drug's market size hinges on its indication, patient population, and competitive alternatives. For instance, if it addresses a prevalent condition such as rheumatoid arthritis or cancer, the addressable market may reach in the hundreds of thousands globally, predominantly influenced by epidemiological trends, diagnostic rates, and access to healthcare services.
Demand is also driven by the therapeutic efficacy, safety profile, and ease of administration relative to competing medications. Additionally, the emergence of biosimilars or generics significantly shifts market dynamics, exerting downward pressure on prices.
Therapeutic Competition
The competitive landscape includes similar branded therapies, biosimilars, and off-label treatments. For NDC 23155-0019, key competitors include:
- Branded alternatives: Leading pharmaceuticals with established market share.
- Biosimilars/generics: Bringing cost competition, especially in mature markets such as the U.S., Europe, and Japan.
Market penetration and prescriber preferences will determine its relative market share, impacting its pricing power.
Regulatory and Reimbursement Environment
Regulatory Status
Assuming NDC 23155-0019 holds FDA approval, its exclusivity period directly influences pricing. Patent protection typically extends for 12-20 years, allowing manufacturers to set premium prices. Once biosimilar or generic entry occurs, price reductions usually follow within 12-24 months.
Reimbursement Policies
Coverage by Medicare, Medicaid, and private insurers significantly influences sales volume and pricing strategies. Reimbursement levels depend on health technology assessments (HTA), formulary placements, and negotiation leverage. In markets with strong HTA evaluations, price ceilings are common, constraining revenue potential.
Pricing Trends and Projections
Current Pricing Status
Current retail and wholesale acquisition costs (WAC) of NDC 23155-0019 will vary depending on indication and market penetration. As a proprietary product with likely patent exclusivity, initial launch prices tend to be premium, often ranging from $10,000 to $50,000 per treatment course, based on similar biologics or targeted therapies.
Future Price Trajectories
Factors influencing price changes include:
- Patent Expiry: Entry of biosimilars could reduce prices 20-40% within 1-3 years of patent expiration.
- Market Competition: Increased competition, especially with biosimilars, typically drives prices downward.
- Regulatory Environment: Government initiatives promoting biosimilars or price controls could further suppress prices.
- Manufacturing and Supply Chain: Cost reductions in production via technological advances can enable price adjustments.
Projected Price Pathways:
- Short-term (1-2 years): Stable or modest decline of 5-10%, maintaining premium positioning due to patent exclusivity.
- Medium-term (3-5 years): Potential price reductions of 15-30% post-biosimilar approval or increased market competition.
- Long-term (beyond 5 years): Prices may stabilize at significantly lower levels, reflecting biosimilar market penetration and increased generics availability.
Economic and Market Impact Factors
- Pricing strategies will adapt to pressure from payers and regulatory trends.
- Market access will hinge on formulary negotiations and unique clinical benefits.
- Pricing dynamics are also influenced by global healthcare policies aiming to curb escalating drug costs.
Key Market Opportunities and Risks
Opportunities:
- Entry into emerging markets with less price sensitivity.
- Development of value-based pricing models linked to clinical outcomes.
- Expanding indications could increase market share and pricing leverage.
Risks:
- Patent litigation or patent cliff leading to generic entry.
- Competitive biosimilar development reducing exclusivity.
- Regulatory changes influencing pricing and market access.
Conclusion
NDC 23155-0019 occupies a potentially lucrative segment, contingent upon its competitive positioning, regulatory protections, and market acceptance. Initial pricing strategies are likely aligned with premium biologics, with prudent anticipation of downward adjustments following patent expiration or increased biosimilar activity. Continuous market monitoring and adaptive pricing approaches will be pivotal for maximizing value.
Key Takeaways
- The current market environment for NDC 23155-0019 is shaped by patent exclusivity, high demand, and limited immediate competition.
- Price projections suggest stability in the short term with gradual declines once biosimilar competition intensifies.
- Entry of biosimilars typically results in 20-40% price reductions within 1-3 years post-patent expiry.
- Market access negotiations and regulatory shifts can significantly influence future pricing trajectories.
- Diversifying indications and expanding into emerging markets represent strategic avenues for sustained revenue growth.
FAQs
1. What factors most influence the pricing of NDC 23155-0019?
Market exclusivity, competitive landscape, regulatory environment, manufacturing costs, and reimbursement policies chiefly determine pricing. Patent protection allows premium pricing, while biosimilar entry exerts downward pressure.
2. How does patent expiration affect the drug’s price?
Patent expiration typically leads to biosimilar or generic entry, causing significant price reductions—generally between 20-40%—and increased market competition.
3. What are the key opportunities to enhance market share for NDC 23155-0019?
Expanding indications, improving clinical positioning, entering emerging markets, and leveraging value-based pricing models can boost market penetration.
4. How do biosimilars impact the long-term pricing of this drug?
Biosimilars increase competition, often leading to substantial price reductions, thereby affecting the original drug’s profitability but expanding treatment access.
5. What regulatory trends could influence future pricing strategies?
Policy initiatives promoting biosimilar adoption, price controls, and value-based reimbursement systems could challenge existing price levels or incentivize new pricing models.
References
- U.S. Food and Drug Administration. National Drug Code Directory.
- IQVIA, Pharmaceutical Market Analysis Reports.
- EvaluatePharma. World Preview of Prescription Drug Trends.
- Centers for Medicare & Medicaid Services. Reimbursement and Pricing Policies.
- IMS Health. Global Trends in Biosimilar Market Dynamics.
Note: Specific data points, including current listings and exact market figures for NDC 23155-0019, require access to proprietary databases or real-time market intelligence reports.
More… ↓
